Story
McKesson to Acquire Precision Medicine Group for $2.25 Billion, Shares Rise

Shares of McKesson Corporation (NYSE:MCK) rose on Tuesday after the company announced a definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion. The deal sent McKesson's stock up by 3.2%, reflecting investor optimism about the strategic expansion into clinical research and biopharmaceutical services.
Deal Details
Under the terms of the agreement, McKesson will acquire Precision Medicine Group (PMG), a global provider of services that support drug development and commercialization for biotechnology and pharmaceutical companies. The transaction is subject to customary closing conditions, including regulatory clearances, and a specific timeline for completion was not disclosed.
Once the acquisition is finalized, PMG will be integrated into McKesson’s Oncology & Multispecialty segment. PMG's offerings include biomarker intelligence, laboratory services, a global clinical research organization, and commercialization support.
AdStrategic Rationale
McKesson stated the acquisition is a key step in advancing its strategy in the high-growth areas of oncology and multispecialty care. The addition of PMG is expected to enhance McKesson's capabilities in clinical trial execution and broaden its service offerings to biopharma partners.
"This acquisition represents another meaningful step in advancing our oncology and multispecialty strategy and reflects our continued commitment to providing patients with access to the highest quality of care," said Brian Tyler, chair and chief executive officer of McKesson, in the announcement. Margaret Keegan, CEO of PMG, added that joining McKesson will provide an opportunity to extend the company's expertise.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.